From PTK-STAT signaling to caspase expression and apoptosis induction

Cell Death and Differentiation

Volumn 6, Issue 12, 1999, Pages 1201-1208

  Fu, X Y ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis induction; Caspase; Gene regulation; Protein tyrosine kinase; STAT

Indexed keywords

CASPASE; CYTOKINE; CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE; STAT PROTEIN;

APOPTOSIS; GENE EXPRESSION REGULATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033372724     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400613     Document Type: Review

References (87)

1. Wyllie AH, Ker JFR and Currie AR (1980) Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-270
2. Ellis RE, Yuan J and Horvitz HR (1991) Mechanisms and functions of cell death. Annu. Rev Cell Biol. 7: 663-698
3. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462
4. Vaux DL and Korsmeyer SJ (1999) Cell Death in Development. Cell 96: 245-254
5. Tata JR (1966). Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. Dev. Biol. 13: 77-94
6. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1449-1456
7. Ashkenazi A and Dixit VM (1998) Death receptors: signaling and modulation. Science 281: 1305-1308
8. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/Ced-3 protease nomenclature. Cell 87: 171
9. Salvesen GS and Dixit VM (1997). Caspases: intracellular signaling by proteolysis. Cell 91: 443-446
10. Thornberry NA and Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
11. Yuan J, Shaham S, Ledoux S, Ellis HM and Horvitz HR (1993)The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641-652
12. Korsmeyer SJ (1995) Regulator of cell death. Trends in Genetics 11: 401-405
13. Reed JC (1995) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 7: 541-546
14. Darnell Jr JE, Kerr IM and Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421
15. Fu X-Y (1995) A direct signaling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors. J. Leukocyte Biol. 57:529-535
16. Chin YE, Kitagawa M, Su W-CS, You Z-H, Iwamoto Y and Fu X-Y (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1. Science 272: 719-722
17. Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17: 5328-5337
18. van der Geer P, Hunter T and Lindberg R (1994) Receptor protein tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell. Biol. 10:251-337
19. Leonard WJ and O'Shea JJ (1998) Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322
20. Schlessinger J and Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9: 383-391
21. Karin M and Hunter T (1995) Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5: 747-757
22. Franke TF, Kaplan DR and Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437
23. Kimchi A (1992) Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50: 1-9
24. Buick RN, Filmus J and Church JG (1991) The role of epidermal growth factor receptors in breast cancer. Cancer Treatment & Research 53: 159-170
25. Brabyn CJ and Kleine LP (1995) EGF causes hyperproliferation and apoptosis in T51B cells: involvement of high and low affinity EGFR binding sites. Cell Signal 7: 139-150
26. Lenardo MJ (1991 ) lnterleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861
27. Hirano T, Nakajima K and Hibi M (1997) Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8: 241-252
28. Fu X-Y (1992) A transcription factor with SH2 and SH3 domains is directly activated by an Interferon α-induced cytoplasmic protein tyrosir e kinase(s). Cell 70: 323-335.47
29. Fu X-Y and Zhang J-J (1993) Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 74: 1135-1145
30. Greenlund AC, Farrar MA, Viviano BL and Schreiber RD (1994) Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13: 1591-1600
31. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE and Yancopoulos GD (1995) Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353
32. Schindler C, Shuai K, Prezioso VR and Darnell Jr JE (1992)Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813
33. Velazquez L, Fellous M, Stark GR and Pellegrini S (1992) A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70: 313-322
34. Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Ha'pur AG, Barbieri G, Witthuhn BA, Schindler C, Pellegrini S, Wilks AF, Ihle JN, Stark GR and Kerr IM (1993) The protein tyrosine kinase JAK1 complements defects in interferon-a/b and -g signal transduction. Nature 366: 129-135
35. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K and Silvennoinen O (1995) Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13: 369-398
36. Ihle JN (1995) Cytokine receptor signalling. Nature 377: 591-594
37. Fu X-Y, Kessler DS, Veals SA, Levy DF and Darnell Jr JE (1990) ISGF3, the transcriptional activator induced by Interferon a, consists of multiple interacting polypeptide chains. Proc. Natl. Acad Sci. USA 87: 8555-8559
38. Kessler DS, Veals SA, Fu XY and Levy DE (1990) Interferon-a regulates nuclear translocation and DNA-binding affinity of ISGF-3; a multimeric transcriptional activator. Genes Dev. 4: 1753-1765
39. Sadowski HB, Shuai K, Darnell Jr JE and Gilman MZ (1993) A common nuc ear signal transduction pathway activated by growth factor and cytokine receptors. Science 261: 1739-1744
40. Silvennoinen O, Ihle JN, Schlessinger J and Levy DE (1993) Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature 366: 583-585
41. Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA and Greene WC (1995) Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc. Natl. Acad. Sci. USA 92: 7192-7196
42. Hou J, Schindler U, Henzel WJ, Wong SC and McKnight SL (1995) Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2: 321-329
43. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell Jr JE and Murphy KM (1995) Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181: 1755-1762
44. Larner AC, David M, Feldman GM, Igarashi K, Hackett RH, Webb DSA, Sweitzer SM, Petricoin EFd and Finbloom DS (1993) Tyrosine phosphcrylation of DNA binding proteins by multiple cytokines. Science 261: 1730-1733
45. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K, et al. (1995a) Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15: 3336-3343
46. Ruff-Jamison S, Chen K and Cohen S (1995) Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc. Natl. Acad. Sci. USA 92: 4215-4218
47. Frank DA, Robertson MJ, Bonni A, Ritz J and Greenberg ME (1995) Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc. Natl. Acad. Sci. USA 92: 7779-7783
48. Darnell Jr JE (1997) STATs and gene regulation. Science 277: 1630-1635
49. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S and Ihle JN (1995b) Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J. Biol. Chem. 270: 20775-20780
50. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81-83
51. Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA and Fu XY (1997) Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386: 288-292
52. Welte T, Leitenberg D, Dittel BN, al-Ramadi BK, BX, Hansen WR, Janeway J, C A, Bothwell ALM, Bottomly K and Fu X-Y (1999) PTK-STAT signaling pathway plays essential roles in T cell activation in response to antigen stimulation. Cold Spring Harbor Symposia on Quantitative Biology 64: In press
53. Bromberg JF, Horvath CM, Wen Z, Schreiber RD and Darnell Jr JE (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 7673-7678
54. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y and Kanakura Y (1997) Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21 (WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17: 2933-2943
55. Xie W, Su K, Wang D, Paterson AJ and Kudlow JE (1997) MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1. Anticancer Res. 17: 2627-2633
56. Bellido T, O'Brien CA, Roberson PK and Manolagas SC (1998) Transcriptional activation of the p21 (WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273: 21137-21144
57. Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C and Comoglio PM (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285-288
58. Iwamoto Y, Chin YE, Peng X and Fu XY (1998) Identification of a membrane-associated inhibitor(s) of epidermal growth factor-induced signal transducer and activator of transcription activation. J. Biol. Chem. 273: 18198-18204
59. McKendry R, John J, Flavell D, Muller M, Kerr IM and Stark GR (1991) High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. USA 88: 11455-11459
60. Leaman DW, Leung S, Li X and Stark GR (1996) Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10: 1578-1588
61. Kumar A, Commane M, Flickinger TW, Horvath CM and Stark GR (1997) Defective TNF-a-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278: 1630-1632
62. Der SD, Zhou A, Williams BRG and Silverman RH (1998) Identification of genes differentially regulated by Interferon alpha, beta, or gamma using oligonucleotide arrays [In Process Citation]. Proc. Natl. Acad. Sci. USA 95: 15623-15628
63. Xu X, Fu XY, Plate J and Chong AS (1998) IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58: 2832-2837
64. Taniguchi T, Harada H and Lamphier M (1995) Regulation of the Interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol. 121: 516-520
65. Fujita T, Reis LFL, Watanabe N, Kimura Y, Taniguchi T and Vilcek J (1989) Induction of the transcription factor IRF-1 and interferon-b mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 86: 9936-9940
66. Pine R, Canova A and Schindler C (1994) Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 13: 158-167
67. TamuraT, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T (1995) An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599
68. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS and Flavell RA (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267: 2000-2003
69. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston CX, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei FY, Wong W, Kamen R and Seshadri T (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endo toxic shock. Cell 80: 401-411
70. Shi L, Chen G, MacDonald G, Bergeron L, Li H, Miura M, Rotello RJ, Miller DK, Li P, Seshadri T, Yuan J and Greenberg AH (1996) Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc. Natl. Acad. Sci. USA 93: 11002-11007
71. Boudreau N, Sympson CJ, Werb Z and Bissell MJ (1995) Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267: 891-893
72. Wang S, Miura M, Jung YK, Zhu H, Li E and Yuan J (1998) Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501-509
73. Friedlander RM, Brown RH, Gagliardini V, Wang J and Yuan J (1997) Inhibition of ICE slows ALS in mice. Nature 388: 31
74. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T and Akira S (1996) STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93: 3963-3966
75. Durbin JE, Hackenmiller R, Simon MC and Levy DE (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450
76. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M and Schreiber RD (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442
77. Sporn MB and Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332: 217-219
78. Altmeyer A, Simmons RC, Krajewski S, Reed JC, Bornkamm GW and Chen-Kiang S (1997) Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation. Immunity 7: 667-677
79. Kim HR, Upadhyay S, Li G, Palmer KC and Deuel TF (1995) Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc. Natl. Acad. Sci. USA 92: 9500-9504
80. Beg AA and Baltimore D (1996) An essential role for NF-κB in preventing TNF-induced cell death. Science 274: 782-784
81. Liu Z-G, Hsu H, Goeddel DV and Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87: 565-575
82. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789
83. Wang CY. Mayo MW and Baldwin ASJ (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787
84. Raff MC (1992) Social controls on cell survival and cell death. Science 356:397-400
85. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115
86. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S and Gouilleux F (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18: 4191-4199
87. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y (1999) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18: 1367-1377